주식/증권
📈 긍정적
BMY Gains 19.4% Year to Date: Should You Buy, Sell or Hold the Stock?
요약
Bristol Myers growth brands and pipeline progress are boosting momentum, but generic pressure on its legacy portfolio warrants caution.